Login

Switch On Your HIV Smarts.

Author Archives: Emily Land

Injectable PrEP: The Next Order of the Day

Injectable PrEP: The Next Order of the Day

, by Emily Land

Two studies are currently investigating a possible long-acting injected version of PrEP. Find out more about this research and what it could mean for HIV prevention. Read More

Capping Coinsurance Payments for PrEP and HIV Meds

Capping Coinsurance Payments for PrEP and HIV Meds

, by Emily Land

Covered California will soon vote on capping the amount consumers have to pay for drugs in the “specialty” tier. Two experts explain what this will mean for people paying for HIV medications and Truvada for PrEP. Read More

DHHS: Atripla No Longer Recommended as First-Line HIV Therapy

DHHS: Atripla No Longer Recommended as First-Line HIV Therapy

, by Emily Land

The U.S. Department of Health and Human Services recently demoted the widely-used HIV combination pill Atripla from first-line HIV therapy recommendations, not because of a problem with the drug itself, but because of the changing landscape in HIV treatment. Read More

Meth, Crack, Coke & Ecstasy: Effects on HIV Disease Progression

Meth, Crack, Coke & Ecstasy: Effects on HIV Disease Progression

, by Emily Land

For the first time, a study investigates whether stimulants lead to poorer health outcomes for people with HIV—independent of antiretroviral use. Read More

Daily Antibiotic Protects Against Chlamydia, Gonorrhea and Syphilis

Daily Antibiotic Protects Against Chlamydia, Gonorrhea and Syphilis

, by Emily Land

A small pilot study reveals that a common antibiotic can help men who have sex with men prevent three common STIs. Read More